Sign Up to like & get
recommendations!
1
Published in 2022 at "Theranostics"
DOI: 10.7150/thno.67300
Abstract: Cancer immunotherapy has made tremendous clinical progress in advanced-stage malignancies. However, patients with various tumors exhibit a low response rate to immunotherapy because of a powerful immunosuppressive tumor microenvironment (TME) and insufficient immunogenicity of tumors.…
read more here.
Keywords:
driven cancer;
immunotherapy;
pdt driven;
cancer immunotherapy ... See more keywords